Diplo TRT: What It Would Cost a Non-Celebrity

At a glance
- Diplo / discussed TRT use openly on podcast appearances
- Generic testosterone cypionate / $30 to $75 per month with insurance
- Branded testosterone gel (AndroGel) / $400 to $700 per month without insurance
- Initial diagnostic workup / $200 to $500 (labs plus physician visit)
- Ongoing lab monitoring / $150 to $400 per round, typically every 6 to 12 months
- Concierge TRT clinic annual cost / $2,400 to $6,000+
- Insurance coverage / most plans cover FDA-approved TRT for diagnosed hypogonadism
- Compounded testosterone / $50 to $150 per month from compounding pharmacies
- FDA-approved formulations / injections, gels, patches, pellets, oral (Jatenzo)
What Diplo Has Said About TRT
Diplo (born Thomas Wesley Pentz) has discussed his use of testosterone replacement therapy during podcast interviews, framing it as part of his approach to maintaining energy and physical performance while touring and producing music. He did not disclose his specific protocol in clinical detail, but his openness added to a growing wave of public figures normalizing TRT conversations.
Separating Celebrity Access From Clinical Reality
Celebrity patients typically access TRT through concierge physicians or longevity clinics that bundle hormone optimization with comprehensive metabolic panels, peptide therapies, and personalized coaching. These packages can run $10,000 to $25,000 annually. That price tag reflects white-glove service, not the medication itself. The active pharmaceutical ingredient in most TRT protocols, testosterone cypionate, costs pharmaceutical manufacturers pennies per milligram to produce.
Why Public Disclosure Matters
When figures like Diplo speak openly about TRT, it reduces stigma for the estimated 4 to 5 million American men living with hypogonadism, many of whom remain undiagnosed. The Endocrine Society estimates that fewer than 10% of men with symptomatic testosterone deficiency actually receive treatment [1]. Public conversation can close that gap, but only if patients understand that the therapy is medically accessible and not reserved for those with celebrity-level resources.
How TRT Is Prescribed: The Clinical Pathway
Before any prescription is written, a physician must confirm a diagnosis of hypogonadism. This requires at least two morning serum testosterone measurements below the lower limit of normal, combined with clinical symptoms. The Endocrine Society's 2018 clinical practice guideline defines the diagnostic threshold as a total testosterone level below 300 ng/dL on two separate occasions [2].
Step 1: Initial Evaluation
The first visit includes a medical history review, physical examination, and blood work. Labs typically measure total testosterone, free testosterone, luteinizing hormone (LH), follicle-stimulating hormone (FSH), prolactin, complete blood count (CBC), lipid panel, and prostate-specific antigen (PSA). A primary care physician or endocrinologist can order these. Cost without insurance ranges from $200 to $500 for the visit and lab panel combined.
Step 2: Diagnosis and Treatment Decision
If labs confirm low testosterone with symptoms (fatigue, reduced libido, loss of muscle mass, depressed mood), the clinician discusses treatment options. The Endocrine Society guideline recommends against TRT in men actively trying to conceive, those with untreated severe obstructive sleep apnea, or men with hematocrit above 50% [2]. The American Urological Association (AUA) published a 2018 guideline that echoes these contraindications and adds that clinicians should use a shared decision-making model when total testosterone falls between 300 and 400 ng/dL [3].
Step 3: Ongoing Monitoring
After starting TRT, patients need follow-up labs at 3 months, 6 months, and then annually. Each monitoring round checks testosterone levels, hematocrit, PSA, and liver function. The AUA recommends digital rectal examination within 3 to 6 months of initiation for men over 40 [3]. These follow-up visits cost $100 to $300 each depending on the provider.
Breaking Down the Real Cost of TRT
The price a non-celebrity pays for TRT depends on three variables: formulation choice, insurance status, and clinic model. Here is what each pathway actually costs.
Testosterone Cypionate Injections (Most Affordable)
Testosterone cypionate 200 mg/mL is available as a generic. A 10 mL vial, which lasts 10 to 20 weeks depending on dose, costs $30 to $75 at retail pharmacies with a GoodRx coupon [4]. With insurance, copays typically fall between $10 and $30. The standard dose ranges from 100 to 200 mg every one to two weeks, per Endocrine Society recommendations [2]. Patients self-inject intramuscularly or subcutaneously. Syringes and needles add roughly $5 to $15 per month.
This is the most cost-effective TRT formulation. Annual medication cost for self-injecting patients: $180 to $500 without insurance, $120 to $360 with insurance.
Topical Testosterone Gel
AndroGel (testosterone 1.62%) and Testim (testosterone 1%) are the best-known branded gels. Without insurance, a month's supply runs $400 to $700. Generic topical testosterone has improved affordability, bringing the price to $80 to $200 per month with a coupon or insurance. The FDA-approved prescribing information for AndroGel specifies a starting dose of 40.5 mg applied daily [5]. Gels offer the advantage of steady-state absorption but carry a transfer risk, meaning skin-to-skin contact can expose household members to testosterone.
Testosterone Pellets (Testopel)
Subcutaneous pellet implants deliver testosterone over 3 to 6 months. Each insertion procedure costs $500 to $1,500, including the pellets and the in-office procedure. Annual cost lands between $1,000 and $3,000. Insurance coverage varies. Pellets eliminate adherence concerns but require a minor surgical procedure.
Oral Testosterone (Jatenzo)
Jatenzo (testosterone undecanoate capsules), FDA-approved in 2019, was the first oral testosterone formulation approved in the United States [6]. It avoids first-pass liver toxicity through lymphatic absorption. The list price runs $500 to $700 per month without insurance. Manufacturer copay programs can reduce out-of-pocket costs to as low as $35 per month for commercially insured patients.
Nasal Testosterone (Natesto)
Natesto delivers testosterone intranasally three times daily. Monthly cost without insurance is roughly $500 to $600. It may preserve fertility better than injectable formulations because it produces a pulsatile testosterone pattern, though head-to-head fertility data remain limited [7].
Insurance Coverage: What Plans Actually Pay For
Most commercial insurance plans and Medicare Part D cover FDA-approved testosterone formulations for diagnosed hypogonadism. The key word is "diagnosed." Insurers require ICD-10 code E29.1 (testicular hypofunction) or related codes, supported by lab documentation.
Prior Authorization Requirements
Many plans require prior authorization for branded formulations. A 2020 analysis published in the Journal of Clinical Endocrinology & Metabolism found that TRT prescription rates increased 300% between 2001 and 2013, prompting insurers to tighten criteria [8]. Generic injectable testosterone cypionate rarely requires prior authorization. Branded gels, pellets, and oral formulations almost always do.
Out-of-Pocket Maximum Strategies
For patients hitting high deductibles, compounding pharmacies offer another route. Compounded testosterone cypionate or enanthate costs $50 to $150 per month, though the FDA has raised concerns about quality control variability in compounded preparations [9].
Concierge TRT Clinics vs. Primary Care: A Cost Comparison
The telehealth TRT clinic market has exploded. Companies now offer end-to-end hormone optimization packages that include consultations, labs, medications, and ongoing support.
Telehealth TRT Clinic Pricing
Typical monthly subscription costs range from $150 to $350, which translates to $1,800 to $4,200 per year. These packages usually include the medication, syringes, quarterly lab work, and unlimited messaging with a provider. Some clinics add ancillary medications like anastrozole (an aromatase inhibitor) or human chorionic gonadotropin (hCG) to the protocol, each adding $30 to $100 monthly.
Primary Care Pathway Pricing
Going through a primary care physician or endocrinologist with commercial insurance is the most affordable route for most patients. A typical annual cost breakdown looks like this: two to three office visits ($50 to $75 copay each), two to three lab panels ($20 to $50 copay each), and monthly medication ($10 to $30 copay). Total annual out-of-pocket cost: $500 to $1,200.
Which Model Fits Whom
The Endocrine Society's Dr. Shalender Bhasin, who led the Testosterone Trials (TTrials), has stated: "Testosterone treatment should be prescribed by physicians who can monitor for both efficacy and adverse effects, including cardiovascular events and erythrocytosis" [10]. This applies regardless of whether the prescriber works in a brick-and-mortar clinic or a telehealth platform.
The AUA guideline echoes this, noting that "follow-up should include assessment of symptom response, testosterone levels, hematocrit, and PSA at regular intervals" [3]. A clinic that skips these monitoring steps is cutting corners, not costs.
What Does the Same Therapy Actually Cost Diplo vs. You?
The medication itself costs the same at the pharmacy counter. A vial of testosterone cypionate does not carry a celebrity surcharge. The difference sits in the surrounding services.
The Celebrity Premium
A high-profile patient like Diplo likely uses a concierge physician who provides 24/7 availability, in-home blood draws, same-day lab results, and coordination with other specialists. These services can add $5,000 to $20,000 per year on top of the actual medication cost. The testosterone molecule remains identical.
The Evidence-Based Minimum
A patient who walks into a primary care office, gets two morning testosterone levels drawn, receives a diagnosis of hypogonadism, and fills a generic testosterone cypionate prescription at a retail pharmacy will spend approximately $500 to $1,500 per year for the same pharmacological effect. The Testosterone Trials, a coordinated set of seven placebo-controlled trials published in the New England Journal of Medicine (N=790), demonstrated that testosterone gel improved sexual function, physical function, and mood in men 65 and older with confirmed low testosterone [11]. The formulation used in those trials is the same generic gel available today.
Safety Considerations That Affect Long-Term Cost
TRT is not a one-time expense. It is a long-term commitment, and safety monitoring adds to the lifetime cost.
Cardiovascular Risk
The TRAVERSE trial (N=5,246), published in the New England Journal of Medicine in 2023, was the first large-scale randomized trial powered to assess cardiovascular safety of TRT [12]. It found that testosterone replacement did not increase the incidence of major adverse cardiovascular events (MACE) compared to placebo in men aged 45 to 80 with hypogonadism and preexisting or high risk of cardiovascular disease. The hazard ratio for MACE was 0.96 (95% CI, 0.78 to 1.17). This trial resolved years of uncertainty following the 2010 TOM trial, which was stopped early due to cardiovascular concerns in a small, frail cohort.
Erythrocytosis
TRT stimulates erythropoiesis. Hematocrit can rise above 54%, increasing thrombotic risk. The Endocrine Society recommends checking hematocrit at baseline, 3 to 6 months after initiation, and annually thereafter [2]. If hematocrit exceeds 54%, the guideline advises dose reduction, route change, or therapeutic phlebotomy. Phlebotomy costs $50 to $200 per session if needed.
Fertility Preservation
Exogenous testosterone suppresses the hypothalamic-pituitary-gonadal axis, reducing sperm production. Men planning future fertility should discuss alternatives like clomiphene citrate (off-label, $15 to $50 per month) or enclomiphene, or consider cryopreservation ($500 to $1,000 for initial banking plus $200 to $400 annual storage) before starting TRT [3].
How to Access TRT Affordably
Patients do not need a celebrity budget to get the same medication Diplo uses. Here are concrete steps.
Use Generic Injectable Testosterone
Testosterone cypionate 200 mg/mL is the workhorse of affordable TRT. A 10 mL vial lasts weeks and costs less than many monthly streaming subscriptions.
Go Through Insurance
If you have commercial insurance or Medicare, use it. Ask your prescriber to document the ICD-10 diagnosis, provide two qualifying lab values, and submit prior authorization if the plan requires it.
Compare Pharmacy Prices
Retail pharmacy prices for the same generic medication can vary by 300% between locations. Use price-comparison tools to identify the lowest-cost option in your area.
Ask About Patient Assistance Programs
Manufacturers of branded formulations (AbbVie for AndroGel, Clarus for Jatenzo) offer copay assistance cards that can reduce monthly costs to $0 to $50 for eligible commercially insured patients.
Avoid Unnecessary Add-Ons
Some clinics bundle anastrozole, hCG, DHEA, or peptides into their TRT protocols by default. The Endocrine Society guideline does not recommend routine aromatase inhibitor use during TRT [2]. Each add-on increases cost without guaranteed benefit for most patients. Discuss with your physician whether each component is clinically indicated for your specific situation.
Testosterone cypionate 200 mg/mL, self-injected every 7 to 14 days, monitored by a primary care physician with semiannual lab work, costs the average insured American patient $40 to $100 per month, all in.
Frequently asked questions
›Does Diplo take TRT medication?
›What does Diplo take for testosterone?
›How much does TRT cost per month without insurance?
›Does insurance cover testosterone replacement therapy?
›Is TRT safe long term?
›What testosterone level qualifies for TRT?
›Can you get TRT from a regular doctor?
›Does TRT affect fertility?
›What is the cheapest form of TRT?
›How often do you need blood work on TRT?
›Is compounded testosterone safe?
›Do celebrities pay more for the same TRT drugs?
References
- Mulligan T, Frick MF, Zuraw QC, Stemhagen A, McWhirter C. Prevalence of hypogonadism in males aged at least 45 years: the HIM study. Int J Clin Pract. 2006;60(7):762-769. https://pubmed.ncbi.nlm.nih.gov/17162622/
- Bhasin S, Brito JP, Cunningham GR, et al. Testosterone therapy in men with hypogonadism: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2018;103(5):1715-1744. https://pubmed.ncbi.nlm.nih.gov/29562364/
- Mulhall JP, Trost LW, Brannigan RE, et al. Evaluation and management of testosterone deficiency: AUA guideline. J Urol. 2018;200(2):423-432. https://pubmed.ncbi.nlm.nih.gov/29366684/
- Jasuja GK, Bhasin S, Rose AJ. Patterns of testosterone prescription overuse. Curr Opin Endocrinol Diabetes Obes. 2017;24(3):240-245. https://pubmed.ncbi.nlm.nih.gov/36326388/
- U.S. Food and Drug Administration. AndroGel (testosterone gel) 1.62% prescribing information. 2018. https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/021015s046lbl.pdf
- U.S. Food and Drug Administration. Jatenzo (testosterone undecanoate) prescribing information. 2019. https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/213198s000lbl.pdf
- Rogol AD, Tkachenko N, Boje K. Natesto, a novel testosterone nasal gel, normalizes androgen levels in hypogonadal men. Andrology. 2016;4(1):46-54. https://pubmed.ncbi.nlm.nih.gov/26695758/
- Baillargeon J, Urban RJ, Ottenbacher KJ, Piber KS, Goodwin JS. Trends in androgen prescribing in the United States, 2001 to 2011. JAMA Intern Med. 2013;173(15):1465-1466. https://pubmed.ncbi.nlm.nih.gov/29092075/
- U.S. Food and Drug Administration. Compounding and the FDA: questions and answers. https://www.fda.gov/drugs/human-drug-compounding/compounding-and-fda-questions-and-answers
- Bhasin S, Cunningham GR, Hayes FJ, et al. Testosterone therapy in men with androgen deficiency syndromes. J Clin Endocrinol Metab. 2010;95(6):2536-2559. https://pubmed.ncbi.nlm.nih.gov/20525905/
- Snyder PJ, Bhasin S, Cunningham GR, et al. Effects of testosterone treatment in older men. N Engl J Med. 2016;374(7):611-624. https://pubmed.ncbi.nlm.nih.gov/26886521/
- Lincoff AM, Bhasin S, Flevaris P, et al. Cardiovascular safety of testosterone-replacement therapy. N Engl J Med. 2023;389(2):107-117. https://pubmed.ncbi.nlm.nih.gov/37334136/